Zolmitriptan Tablet, Film Coated
Product Images NDC 62332-463

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 62332-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolmitriptan-25mgtabs.jpg (Zolmitriptan 25mgtabs)

Packaging label for Zolmitriptan Tablets, USP 2.5 mg, an oral film-coated tablet by Alembic Pharmaceuticals Inc. The label indicates unit-dose tablets with a package size of 6 tablets (1 x 6). The front displays the product name, strength, and manufacturer, along with Rx only status and barcodes.*

FDA Label Image

Zolmitriptan-5mgtabs.jpg (Zolmitriptan 5mgtabs)

Packaging label for Zolmitriptan Tablets, USP 5 mg, film-coated oral tablets by Alembic Pharmaceuticals Inc. The box contains 3 unit-dose tablets (1 x 3). The label includes NDC 62332-463-03 and features multiple barcodes and usage warnings.*

FDA Label Image

Zolmitriptan-fig1.jpg (Zolmitriptan Fig1)

A line chart showing the estimated probability of response over time from initial dose for zolmitriptan at 1 mg, 2.5 mg, and 5 mg doses compared to placebo. The x-axis represents time in hours (0 to 4 hours), and the y-axis shows response probabilities from 0% to 100%, illustrating dose-related response trends.*

FDA Label Image

Zolmitriptan-fig2.jpg (Zolmitriptan Fig2)

A line graph showing the estimated probability of medication or rescue over 24 hours from the initial dose for various treatments including placebo and zolmitriptan doses (1 mg, 2.5 mg, 5 mg). The x-axis represents time in hours, and the y-axis shows the probability percentage, with higher doses generally associated with higher probabilities of medication or rescue use compared to placebo.*

FDA Label Image

Structure (Zolmitriptan Str)

Chemical structure of zolmitriptan, showing its molecular framework with rings and functional groups characteristic of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.